Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Kerneis

Showing results (21-30 of 146) with videos related to

Pageof 15
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and durationPierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitationsMichel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Journal of Thrombosis and Thrombolysis|September 20, 2019
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysisWilliam J Gibson, Tarek Nafee, Ryan Travis, et al.
European Journal of Preventive Cardiology|May 14, 2025
Cardiovascular and Obstetric Safety of Pregnancy In Women With Premature Coronary Artery DiseaseMeryem Mikou, Niki Procopi, Mathieu Kerneis, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 5, 2019
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?Michel Zeitouni, Mathieu Kerneis, Benoit Lattuca, et al.
The New England Journal of Medicine|June 13, 2019
Abatacept for Severe Immune Checkpoint Inhibitor-Associated MyocarditisJoe-Elie Salem, Yves Allenbach, Aurore Vozy, et al.
Drugs & Aging|April 7, 2019
Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered ApproachBenoit Lattuca, Mathieu Kerneis, Michel Zeitouni, et al.
Annals of Intensive Care|January 6, 2024
Authors reply in response to a letter on: "Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support"Marc Pineton de Chambrun, Yann Marquet, Mathieu Kerneis, et al.
Annals of the Rheumatic Diseases|November 21, 2020
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Ventura <i>et al'</i>Juliette Chommeloux, Marie Pouletty, Naim Ouldali, et al.
The American Journal of Cardiology|September 16, 2018
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)Fahad AlKhalfan, Mathieu Kerneis, Tarek Nafee, et al.
Pageof 15

Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and durationPierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 12, 2020
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitationsMichel Zeitouni, Pierre Sabouret, Mathieu Kerneis, et al.
Journal of Thrombosis and Thrombolysis|September 20, 2019
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysisWilliam J Gibson, Tarek Nafee, Ryan Travis, et al.
European Journal of Preventive Cardiology|May 14, 2025
Cardiovascular and Obstetric Safety of Pregnancy In Women With Premature Coronary Artery DiseaseMeryem Mikou, Niki Procopi, Mathieu Kerneis, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 5, 2019
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?Michel Zeitouni, Mathieu Kerneis, Benoit Lattuca, et al.
The New England Journal of Medicine|June 13, 2019
Abatacept for Severe Immune Checkpoint Inhibitor-Associated MyocarditisJoe-Elie Salem, Yves Allenbach, Aurore Vozy, et al.
Drugs & Aging|April 7, 2019
Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered ApproachBenoit Lattuca, Mathieu Kerneis, Michel Zeitouni, et al.
Annals of Intensive Care|January 6, 2024
Authors reply in response to a letter on: "Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support"Marc Pineton de Chambrun, Yann Marquet, Mathieu Kerneis, et al.
Annals of the Rheumatic Diseases|November 21, 2020
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Ventura <i>et al'</i>Juliette Chommeloux, Marie Pouletty, Naim Ouldali, et al.
The American Journal of Cardiology|September 16, 2018
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)Fahad AlKhalfan, Mathieu Kerneis, Tarek Nafee, et al.
Pageof 15